Johnson & Johnson fall around 10% from peak, partly due to Q4 result lower than expected and lower sales as a result of high US$ reduced its international revenues. I think its one of the best company to hold whenever it drops a bit.
In the past 100 years, Johnson & Johnson, a leader in health care products & equipments. it's share price rised around 11% per year for the past 100 years and it is one of the corporation now day still have a AAA credit rating in USA.
Bilibala has recently doubled its holding in Johnson & Johnson (US$101). The fund invested in this corporation since 2009 with an average cost of US$70 (before added).
In the past 100 years, Johnson & Johnson, a leader in health care products & equipments. it's share price rised around 11% per year for the past 100 years and it is one of the corporation now day still have a AAA credit rating in USA.
Bilibala has recently doubled its holding in Johnson & Johnson (US$101). The fund invested in this corporation since 2009 with an average cost of US$70 (before added).
Posts
No comments:
Post a Comment